相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug
Apostolos Tzikas et al.
EUROINTERVENTION (2016)
Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation
Hans T. H. Tu et al.
INTERNATIONAL JOURNAL OF STROKE (2015)
The budget impact of left atrial appendage closure compared with adjusted-dose warfarin and dabigatran etexilate for stroke prevention in atrial fibrillation
Stacey L. Amorosi et al.
EUROPACE (2014)
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion
Bernhard Meier et al.
EUROPACE (2014)
Current and new oral antithrombotics in nonvalvular atrial fibrillation: a network meta-analysis of 79 808 patients
Ariel Dogliotti et al.
HEART (2014)
Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial Fibrillation A Randomized Clinical Trial
Vivek Y. Reddy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy
David R. Holmes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Economic Evaluation of Percutaneous Left Atrial Appendage Occlusion, Dabigatran, and Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation
Sheldon M. Singh et al.
CIRCULATION (2013)
All-cause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study
Tommy Andersson et al.
EUROPEAN HEART JOURNAL (2013)
Population-based study of acute- and long-term care costs after stroke in patients with AF
Ramon Luengo-Fernandez et al.
INTERNATIONAL JOURNAL OF STROKE (2013)
Left Atrial Appendage Closure With the Watchman Device in Patients With a Contraindication for Oral Anticoagulation The ASAP Study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)
Vivek Y. Reddy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study
Leif Friberg et al.
EUROPEAN HEART JOURNAL (2012)
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
A. John Camm et al.
EUROPEAN HEART JOURNAL (2012)
Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) Score
Gregory Y. H. Lip et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial
David R. Holmes et al.
LANCET (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies
Karsten Bruins Slot et al.
BRITISH MEDICAL JOURNAL (2008)
Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care
S. DeWilde et al.
HEART (2006)
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction - Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and Morbidity (CHARM) program
Lars G. Olsson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: A systematic review and meta-analysis
Gregory Y. H. Lip et al.
THROMBOSIS RESEARCH (2006)
Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK
S Stewart et al.
HEART (2004)
Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation
BF Gage et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
AS Go et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
分享论文
